GEVA

Synageva Biopharma Corp

A biopharmaceutical company that began in 1996 as AviGenics, a University of Georgia startup that engineered chickens to produce human therapeutic proteins inside their egg whites. After a new chief executive arrived in 2008, it pivoted to making medicines for rare diseases and renamed itself Synageva, going on to develop a drug for lysosomal acid lipase deficiency before being absorbed into Alexion Pharmaceuticals.

Recent Activity

Show $

2015Q2

1 sell

ArrowMark PartnersEXIT

-162.0K shares

ArrowMark PartnersEXIT

-162.0K shares

2015Q1

1 sell

ArrowMark PartnersTRIM

-77.7K shares(-32.4%)

ArrowMark PartnersTRIM

-77.7K shares(-32.4%)

Loading more activity...